RecruitingNot ApplicableNCT04792697

Experimental Manipulation of Sleep and Circadian Rhythms and the Role Played on Reward Function in Teens

Center for Adolescent Reward, Rhythms and Sleep Project 2


Sponsor

University of Pittsburgh

Enrollment

100 participants

Start Date

May 1, 2021

Study Type

INTERVENTIONAL

Conditions

Summary

Adolescence is a time of heightened reward sensitivity and greater impulsivity. On top of this, many teenagers experience chronic sleep deprivation and misalignment of their circadian rhythms due to biological shifts in their sleep/wake patterns paired with early school start times. Many studies find that this increases the risk for substance use (SU). However, what impact circadian rhythm and sleep disruption either together or independently have on the neuronal circuitry that controls reward and cognition, or if there are interventions that might help to modify these disruptions is unknown. Project 2 (P2) of the CARRS center will test an innovative and mechanistic model of brain circuitry that uses multi-method approaches, takes a developmental perspective, and incorporates key sleep and reward constructs.


Eligibility

Min Age: 13 YearsMax Age: 15 Years

Inclusion Criteria4

  • Typically enrolled in a traditional high-school with synchronous learning (in-person or online synchronous learning, but not cyber- or home-schooling) \[school closures during the COVID-19 pandemic are an exception to this\]
  • Physically and psychiatrically healthy
  • Provision of written informed consent and assent
  • Additional inclusion criterion for Experimental protocol: Meets operational definition of late sleep timing (>10:50PM habitual bedtime)

Exclusion Criteria12

  • History of alcohol, cannabis, or illicit drug use in the past month, or greater than monthly use in the past year
  • Significant or unstable acute or chronic medical conditions
  • Frequent headaches or migraines
  • History of seizures
  • Current serious psychiatric disorder (e.g., depressive disorder, bipolar disorder, eating disorder, psychotic disorder diagnosis, alcohol use disorder or substance use disorder) that would interfere with completion of study procedures
  • Current syndromal sleep disorders other than insomnia and delayed sleep phase disorder
  • MRI contraindications (i.e., absence of metal in the body, claustrophobia)
  • Medications that increase sensitivity to blue light/photosensitizing medications, including psychiatric neuroleptic drugs, psoralen drugs, antiarrhythmic drugs, etc.
  • Changes to psychotropic medication regimen in the 2 weeks prior to enrollment, and/or major changes to medications during the study protocol
  • If participants have an average bedtime that is later than 3:00AM or an average wake time later than 11:00AM they may be excluded from the study
  • Participants should be EXCLUDED for other sleep disorders that require ongoing treatment
  • Participants should be EXCLUDED for other sleep disorders that cause significant distress or impairment, per DSM 5 criteria in the Sleep SCID.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERIncrease morning bright light

Participants will wear Re-Timer bright glasses for 30 minutes each morning upon rising

OTHERDecrease evening blue light

Participants will wear tinted glasses that block blue wavelength light for 2 hours before bed

BEHAVIORALSleep Scheduling

Participants will advance their bedtime by 1.5 hours and regularize their wake time

BEHAVIORALMonitor sleep, mood, and substance use

Participants will complete smartphone-based sleep, mood, and substance use monitoring


Locations(1)

Western Psychiatric Hospital

Pittsburgh, Pennsylvania, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT04792697


Related Trials